Global Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus Syndrome Market, By Symptoms (Polymicrogyria, Megalencephaly, Intellectual Disability, Seizures, Polydactyly, Hydrocephalus), Treatment (Neurosurgery, Genetic Therapy, Drugs, Others), Route of Administration (Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028